Sentence examples for false patents from inspiring English sources

The United States Federal Trade Commission has opened an investigation into whether the Elan Corporation, an Irish drug maker, used unfair practices like listing false patents to prevent development of generic versions of Skelaxin, a muscle relaxant that Elan agreed to sell with other assets in January to King Pharmaceuticals of Bristol, Tenn., for $850 million.

Some magicians, writes Simon During, a professor at Johns Hoplins University and author of Modern Enchantments: The Cultural Power of Secular Magic, try to solve this conundrum by planting false patents to throw off competitors.

Handling costly legal surprises such as false patent marking suits requires focused attention from managers.

We apply automated content analysis to official court records for 992 false patent marking cases (2009 2011) and quantify competing risks using hazard models.

Our study explores false patent marking suits, a unique type of patent-related legal surprise involving allegations of defendants marking products with ineligible patent numbers to deceive customers and/or deter competitors.

In February 2010, Activision was sued by the Patent Compliance Group (PCG) for releasing Guitar Hero products with false patent claims, with the PCG asserting that games like Guitar Hero 5 and Band Hero were marked with up to 10 patents that are not used within the games along with several other improper patent pending claims.

Intel's suit filed with the North California District Court in San Jose charges VIA with breach of contract since March, false advertising, patent infringement and unfair competition.

Intel filed its suit, claiming that since March Via was in breach of contract and has engaged in false advertising, patent infringement and unfair competition.

Type II endoleak is associated with residual blood flow into the aneurysmatic sac or the false lumen from patent intercostals arteries, bronchial arteries, or patent LSA.

The competition between Riddell and Schutt has long extended to the courtroom, from an antitrust case to current reciprocal actions over false advertising and patent infringement.

Therefore, patients with a patent false lumen should be followed up carefully.